Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. - Wikidata - wikimedia - TriplyDB

Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q30431831

about

Risk-reducing medication for primary breast cancer: a network meta-analysis Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake Combination of Antiestrogens and Omega-3 Fatty Acids for Breast Cancer Prevention Exemestane for breast cancer prevention: a critical shift?Physician and Patient Barriers to Breast Cancer Preventive Therapy Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials Atypical epithelial hyperplasia of the breast: state of the art.Quality of Life, Perceptions, and Health Satisfaction of Older Adults with End-Stage Renal Disease: A Systematic Review.CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral.How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?What Matters to Women When Making Decisions About Breast Cancer Chemoprevention?Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630.Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk Risk-benefit profiles of women using tamoxifen for chemoprevention.Major clinical research advances in gynecologic cancer in 2011.Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.Acceptance and adherence to chemoprevention among women at increased risk of breast cancer Exemestane in the prevention setting Chemoprevention for Breast Cancer.My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.Tamoxifen Initiation After Ductal Carcinoma In Situ.Barriers and Facilitators to Patient-Provider Communication When Discussing Breast Cancer Risk to Aid in the Development of Decision Support Tools.Affective forecasting and medication decision making in breast-cancer prevention Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer.Establishing a program for individuals at high risk for breast cancer.Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention.Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010 Pharmacogenomics of endocrine therapy in breast cancer.Usability Testing of a Web-Based Decision Aid for Breast Cancer Risk Assessment Among Multi-Ethnic Women.Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic.Decision making for breast cancer prevention among women at elevated risk Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.Aromatase inhibitors and breast cancer prevention.The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.Suitable trial designs and cohorts for preventive breast cancer agents.

P2860

Q24185817-6E4F0675-1D42-4ED8-BEDC-58860DDBDA2F Q26773464-1DBB0088-81D8-46FD-A932-9D0B4F753F60 Q26774593-7901DEE1-7031-46E5-A958-5C0C18575105 Q26784486-59639D6D-1F00-49D5-8C52-E81932D0C5EE Q27028211-A371A249-B0C6-4C74-8E57-E1EB5BCF747A Q28072526-282F5A41-361D-4BA6-9E29-9B87061543A0 Q28269986-B536FE31-7F1F-43CC-8AAA-CB10F3AD8969 Q30249199-D7BA8FE6-0C89-49BB-A8DF-E38FDF5D6AE7 Q30275194-40235D3B-4B06-4F05-BC91-49D1FD7F5920 Q30400967-E898127A-C5D3-4701-AA42-D1078DA10E56 Q31157610-9F595B50-02D8-4602-AEAB-060A529A3683 Q33767120-3B5ED392-085C-4887-916E-36D63D075CAC Q33910927-6E9F1DAB-23B9-4C70-8623-7E73E307C2C7 Q33915034-F5159002-E6C6-41DC-9779-68D25F9A1585 Q34044916-80048AA7-F528-4AC1-9F85-F3535D4D5E4C Q34974865-C3E352EB-54C5-4278-B084-8010457F655C Q35758722-0804DED2-5690-46A1-AD93-159BBE934C9B Q35777905-113BC8FE-B9A8-48DF-BED6-9DBB60922191 Q35812120-F8E5B4E0-331B-4313-87A3-3A0C54115AF6 Q35854935-33E31904-0E9D-4E59-86A9-66EE307AB50E Q35949285-29367B31-2C83-40EB-9E69-A6B4C5AB8261 Q35998680-44F5944F-B96B-41FF-A565-E0F21D3BE530 Q36117814-1C7F4EEB-BE30-4226-B63E-6377C8D8F1D8 Q36349610-7D4BE4FF-1A8C-44A9-B984-C59AF85447A5 Q36558404-A69899B6-5A38-468C-8B7C-76CC80AEBCCF Q36613582-A757A296-32FF-4B3D-A940-A6C608E588F8 Q36905513-DD9AB866-0CCD-4947-8D1C-245BB8F2CA2E Q36947842-9B33627B-3491-414B-B46F-515B1DF73459 Q36983389-25B1FA5F-49F3-47BB-A4DD-5E03840784E3 Q37009636-A557D4FC-DB9E-4B7A-B66E-25BDD77571D8 Q37097084-398C0A18-CEC7-4C5B-BB7E-967A90B7DB5D Q37165630-1EEF6600-3DE0-43DB-B2AB-FDBBB2702D74 Q37588045-63EB4264-54B0-4FC5-93DA-CFC975E93D3C Q37676534-ABB77213-10D9-45D0-91E7-823B239682B7 Q37681706-B7C7FC5C-380A-45EE-89EC-D385EB5D67DF Q37720955-B1EFFAA6-A75A-44E8-941E-B97819861394 Q37955050-F45EDDEA-FE90-484B-BE97-A9959AF28BE0 Q37975542-25AE2111-A8A9-4F41-BB92-8DC2DC8D6E81 Q38057146-D5E72A2C-F9F6-4993-BDA0-331AA13BD9D2 Q38150222-329323BF-3E23-45D9-88D8-12B0CB3279C2

P2860

Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q30431831

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Patient decisions about breast ...... atic review and meta-analysis.

@ast

Patient decisions about breast ...... atic review and meta-analysis.

@en

type

label

Patient decisions about breast ...... atic review and meta-analysis.

@ast

Patient decisions about breast ...... atic review and meta-analysis.

@en

prefLabel

Patient decisions about breast ...... atic review and meta-analysis.

@ast

Patient decisions about breast ...... atic review and meta-analysis.

@en

P1433

Q30431831-E8C15A96-3642-4BCE-887F-A117DD458C9C

P1476

Q30431831-6F1B35CC-1F0B-48F6-948A-9A391769BA9A

P2093

Q30431831-2279A5AF-4942-47D4-B1B1-EB03C09957B9

Q30431831-26C90F44-AF45-40F3-87D3-81C65008413E

Q30431831-328DA7B9-E653-4792-B7FE-03B8DC4777CD

P2860

Q30431831-04969D7C-9E4F-4D1F-BF4F-8F4883FD243C

Q30431831-0D6D499D-DDD2-4DF2-B753-C6067EBA6DDA

Q30431831-2CCF9B25-DE55-4475-94CF-AAD3CB9ECF7A

Q30431831-2EACFC57-C980-47AD-B612-0288E5CF2FE4

Q30431831-3D66B4A5-692B-4BDE-B6E7-AE9173968890

Q30431831-47A735F4-FE88-469B-9027-3C4FAFA9771A

Q30431831-5517BA8B-CE04-4525-82BD-4F67A5999585

Q30431831-6F21A5BE-AD27-4CCC-B25D-35917B396CB2

Q30431831-7FF8E479-094E-4F58-9234-B86B54CF101C

Q30431831-8265D05D-FABF-4F7B-8AA8-B337A77B0CFA

P304

Q30431831-CAA9EBC3-6AA8-4B48-848A-860C3B28E1A1

P31

Q30431831-6E35044D-5D4A-431A-811D-9EB94D717DCB

Q30431831-8003B0A8-7F65-4011-9B9F-18665DD60B2C

Q30431831-B074652E-53DF-4F5A-9DB2-33ADF7BB0176

P356

Q30431831-8175F7BF-58AB-4ADA-90E8-B681E754AD23

P407

Q30431831-A93E0777-CDD7-4677-A244-D691BCEA012D

P433

Q30431831-D06EA68E-1C44-4A11-9E6F-838C4EB4A0F5

P478

Q30431831-37120B55-B6E9-40E5-9293-6E85E86B11DA

P577

Q30431831-758861E5-9DA4-4954-B581-E9AE4F08F4F1

P5875

Q30431831-97F2DEA2-DC4B-4E97-B69C-66BE1AF78BA4

P698

Q30431831-D50E02FA-ADD6-4123-A921-26A8A2D749A8

P921

Q30431831-53345F21-A6B2-4EE0-91D0-397CC97AE261

P932

Q30431831-A7262E8C-DAD6-4D34-99FF-067398AB8117

P356

JCO.2009.27.8077

P1433

Journal of Clinical Oncology

P1476

Patient decisions about breast ...... atic review and meta-analysis.

@en

P2093

Jess Keim

http://www.w3.org/2001/XMLSchema#string

John T Philbrick

http://www.w3.org/2001/XMLSchema#string

Mary E Ropka

http://www.w3.org/2001/XMLSchema#string

P2860

Proportional odds ratio model for comparison of diagnostic tests in meta-analysis.

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

Repeated-measures modeling improved comparison of diagnostic tests in meta-analysis of dependent studies.

Risk communication in practice: the contribution of decision aids.

American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene.

Unwarranted variations in healthcare delivery: implications for academic medical centres

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group.

Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump

P304

3090-3095

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1200/JCO.2009.27.8077

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44587859

http://www.w3.org/2001/XMLSchema#string

P698

20458026

http://www.w3.org/2001/XMLSchema#string

P921

P932

2903338

http://www.w3.org/2001/XMLSchema#string